Search NASA⌕ Search

Engineering topics

Lim, S

Publications and source records attributed to Lim, S.

SU-C-BRB-01: Automated Dose Deformation for Re-Irradiation

Purpose: An objective of retreatment planning is to minimize dose to previously irradiated tissues. Conventional retreatment planning is based largely on best-guess superposition of the previous treatment’s isodose lines. In this study, we report a rigorous, automated retreatment planning process to minimize dose to previously irradiated organs at risk (OAR). Methods: Data for representative patients previously treated using helical tomotherapy and later retreated in the vicinity of the original disease site were retrospectively analyzed in an automated fashion using a prototype treatment planning system equipped with a retreatment planning module (Accuray, Inc.). The initial plan’s CT, structures, and planned dose were input along with the retreatment CT and structure set. Using a deformable registration algorithm implemented in the module, the initially planned dose and structures were warped onto the retreatment CT. An integrated third-party sourced software (MIM, Inc.) was used to evaluate registration quality and to contour overlapping regions between isodose lines and OARs, providing additional constraints during retreatment planning. The resulting plan and the conventionally generated retreatment plan were compared. Results: Jacobian maps showed good quality registration between the initial plan and retreatment CTs. For a right orbit case, the dose deformation facilitated delineating the regions of the eyes and optic chiasm originally receiving 13 to 42 Gy. Using these regions as dose constraints, the new retreatment plan resulted in V50 reduction of 28% for the right eye and 8% for the optic chiasm, relative to the conventional plan. Meanwhile, differences in the PTV dose coverage were clinically insignificant. Conclusion: Automated retreatment planning with dose deformation and definition of previously-irradiated regions allowed for additional planning constraints to be defined to minimize re-irradiation of OARs. For serial organs that do not recover from radiation damage, this method provides a more precise and quantitative means to limit cumulative dose. This research is partially supported by Accuray, Inc.

60 APPLIED LIFE SCIENCES↗

SU-F-T-226: QA Management for a Large Institution with Multiple Campuses for FMEA

Purpose: To redesign our radiation therapy QA program with the goal to improve quality, efficiency, and consistency among a growing number of campuses at a large institution. Methods: A QA committee was established with at least one physicist representing each of our six campuses (22 linacs). Weekly meetings were scheduled to advise on and update current procedures, to review end-to-end and other test results, and to prepare composite reports for internal and external audits. QA procedures for treatment and imaging equipment were derived from TG Reports 142 and 66, practice guidelines, and feedback from ACR evaluations. The committee focused on reaching a consensus on a single QA program among all campuses using the same type of equipment and reference data. Since the recommendations for tolerances referenced to baseline data were subject to interpretation in some instances, the committee reviewed the characteristics of all machines and quantified any variations before choosing between treatment planning system (i.e. treatment planning system commissioning data that is representative for all machines) or machine-specific values (i.e. commissioning data of the individual machines) as baseline data. Results: The configured QA program will be followed strictly by all campuses. Inventory of available equipment has been compiled, and additional equipment acquisitions for the QA program are made as needed. Dosimetric characteristics are evaluated for all machines using the same methods to ensure consistency of beam data where possible. In most cases, baseline data refer to treatment planning system commissioning data but machine-specific values are used as reference where it is deemed appropriate. Conclusion: With a uniform QA scheme, variations in QA procedures are kept to a minimum. With a centralized database, data collection and analysis are simplified. This program will facilitate uniformity in patient treatments and analysis of large amounts of QA data campus-wide, which will ultimately facilitate FMEA.

43 PARTICLE ACCELERATORS↗

SU-F-T-562: Validation of EPID-Based Dosimetry for FSRS Commissioning

Purpose: The prevailing approach to frameless SRS (fSRS) small field dosimetry is Gafchromic film. Though providing continuous information, its intrinsic uncertainties in fabrication, response, scan, and calibration often make film dosimetry subject to different interpretations. In this study, we explored the feasibility of using EPID portal dosimetry as a viable alternative to film for small field dosimetry. Methods: Plans prescribed a dose of 21 Gy were created on a flat solid water phantom with Eclipse V11 and iPlan for small static square fields (1.0 to 3.0 cm). In addition, two clinical test plans were computed by employing iPlan on a CIRS Kesler head phantom for target dimensions of 1.2cm and 2.0cm. Corresponding portal dosimetry plans were computed using the Eclipse TPS and delivered on a Varian TrueBeam machine. EBT-XD film dosimetry was performed as a reference. The isocenter doses were measured using EPID, OSLD, stereotactic diode, and CC01 ion chamber. Results: EPID doses at the center of the square field were higher than Eclipse TPS predicted portal doses, with the mean difference being 2.42±0.65%. Doses measured by EBT-XD film, OSLD, stereotactic diode, and CC01 ion chamber revealed smaller differences (except OSLDs), with mean differences being 0.36±3.11%, 4.12±4.13%, 1.7±2.76%, 1.45±2.37% for Eclipse and −1.36±0.85%, 2.38±4.2%, −0.03±0.50%, −0.27±0.78% for iPlan. The profiles measured by EPID and EBT-XD film resembled TPS (Eclipse and iPlan) predicted ones within 3.0%. For the two clinical test plans, the EPID mean doses at the center of field were 2.66±0.68% and 2.33±0.32% higher than TPS predicted doses. Conclusion: We found that results obtained with EPID portal dosimetry were slightly higher (∼2%) than those obtained with EBT-XD film, diode, and CC01 ion chamber with the exception of OSLDs, but well within IROC tolerance (5.0%). Therefore, EPID has the potential to become a viable real-time alternative method to film dosimetry.

60 APPLIED LIFE SCIENCES↗

SU-F-T-613: Multi-Lesion Cranial SRS VMAT Plan Quality

Purpose: Cranial SRS VMAT plans must have steep dose gradient around each target to reduce dose to normal brain. This study reports on the correlation between gradient index (GI=V50%/V100%), target size and target dose heterogeneity index (HI=PTV Dmax/prescription dose) for multi-lesion cranial SRS VMAT plans. Methods: VMAT plans for 10 cranial cases with 3 to 6 lesions (total 39 lesions) generated in Varian Eclipse V11.0.47 with a fine-tuned AAA beam model and 0.125 cm dose grid were analyzed. One or two iso centers were used depending on the spatial distribution of lesions. Two to nine coplanar and non-coplanar arcs were used per isocenter. Conformity index (CI= V100%/VPTV), HI, and GI were determined for each lesion. Dose to critical structures were recorded. Results: Lesion size ranged from 0.05–11.00 cm3. HI ranged from 1.2–1.4, CI ranged from 1.0–2.8 and GI from 3.1–8.4. Maximum dose to brainstem, chiasm, lenses, optic nerves and eyes ranged from 120–1946 cGy, 47–463 cGy, 9–121 cGy, 14–512 cGy, and 17–294 cGy, respectively. Brain minus PTV (Brain-PTV) V7Gy was in the range 1.1–6.5%, and Brain-PTV Dmean was in the range 94–324 cGy. Conclusion: This work shows that a GI < 5 can be achieved for lesions > 0.4cc. For smaller lesions, GI increases rapidly. GI is lower when HI is increased. Based on this study, recommend HI is 1.4, and recommended GI is for volumes <0.1cc GI<9, 0.1–0.4cc GI<6, 0.4–0.1.0cc GI<5, and for volumes >1.0cc GI<4. CI is < 1.3 for all lesions except for targets < 0.1cc. Cranial SRS VMAT plans must be optimized to lower the GI to reduce the dose to normal brain tissue.

60 APPLIED LIFE SCIENCES↗

SU-G-BRC-05: Conundrum for VMAT Cranial Multiple Lesions Treated with HD120 MLC

Purpose: To commission a custom 6MV-SRS-AAA Eclipse beam model for VMAT multiple lesions cranial SRS treatment on a Varian TrueBeam STx. Methods: Six clinical plans were created using a customized beam model with dosimetric-leaf-gap(DLG) optimized for clinical treatments. Each plan had 4–6 non-isocentric targets with size from 0.2 to 7.1cc. All fields were measured with EBT3 film in the coronal plane in a solid water phantom and with an AS1000 EPID using gantry rotation. In addition, an end-to-end test was performed with coronal and sagittal films in an anthropomorphic phantom verifying dosimetry and localization accuracy. Portal dose distributions were generated with a custom portal dosimetry algorithm(PDIP). Measured dose distributions were compared with calculations using average dose difference (DD), and gamma function, γ. Using a 1.25mm grid, the γ criteria, local DD ≤ 3% and 2mm distance-to-agreement, were applied in regions with dose 50% of maximum. Results: The respective DD and γ for all films were <±2% and >94.2%. The portal dose γ scores for all the plans were >94.9%. However, local regions with underdose >10%, were observed when targets were treated with the 5mm leaves. The same plans re-optimized with two isocenters such that all lesions were under the 2.5mm leaves did not show this effect. The DD and localization error of the end-to-end test were within 3.4% and 1.0mm respectively. Conclusion: The custom AAA beam model is capable of calculating acceptable dosimetry for targets using only the 2.5 mm leaves. This restricts lesions to within ±4cm of isocenter. The observed underdose beneath the 5mm leaves is attributed to a limitation in Eclipse that uses a single DLG representing the DLG’s of both 2.5mm and 5mm leaves. If lesions are >4cm from isocenter, a multiple isocenter technique should be considered to allow the use of only the 2.5mm leaves.

60 APPLIED LIFE SCIENCES↗

SU-G-TeP2-01: Can EPID Based Measurement Replace Traditional Daily Output QA On Megavoltage Linac?

Purpose: To investigate the long term stability and viability of using EPID-based daily output QA via in-house and vendor driven protocol, to replace conventional QA tools and improve QA efficiency. Methods: Two Varian TrueBeam machines (TB1&TB2) equipped with electronic portal imaging devices (EPID) were employed in this study. Both machines were calibrated per TG-51 and used clinically since Oct 2014. Daily output measurement for 6/15 MV beams were obtained using SunNuclear DailyQA3 device as part of morning QA. In addition, in-house protocol was implemented for EPID output measurement (10×10 cm fields, 100 MU, 100cm SID, output defined over an ROI of 2×2 cm around central axis). Moreover, the Varian Machine Performance Check (MPC) was used on both machines to measure machine output. The EPID and DailyQA3 based measurements of the relative machine output were compared and cross-correlated with monthly machine output as measured by an A12 Exradin 0.65cc Ion Chamber (IC) serving as ground truth. The results were correlated using Pearson test. Results: The correlations among DailyQA3, in-house EPID and Varian MPC output measurements, with the IC for 6/15 MV were similar for TB1 (0.83–0.95) and TB2 (0.55–0.67). The machine output for the 6/15MV beams on both machines showed a similar trend, namely an increase over time as indicated by all measurements, requiring a machine recalibration after 6 months. This drift is due to a known issue with pressurized monitor chamber which tends to leak over time. MPC failed occasionally but passed when repeated. Conclusion: The results indicate that the use of EPID for daily output measurements has the potential to become a viable and efficient tool for daily routine LINAC QA, thus eliminating weather (T,P) and human setup variability and increasing efficiency of the QA process.

60 APPLIED LIFE SCIENCES↗

SU-E-P-16: A Feasibility Study of Using Eclipse AAA for SRS Treatement

Purpose: To commission Varian Eclipse AAA for SRS treatment and compare the accuracy with Brainlab iPlan system for clinical cases measured with radiochromic film. Methods: A 6MV AAA clinical model for a Varian TrueBeam STx is used as baseline. The focal spot and field size of the baseline model(BASE) are (1.75,0.75) and 40×40cm{sup 2} respectively. Maximum field sizes, output factors(S{sub t}), FWHM focal spot and secondary source sizes are systematically adjusted to obtain an optimized model(OPT) by comparing the calculated PDD’s, profiles, and output factors with measurements taken with a stereotactic diode(SD) and, cc01 and cc04 ion chambers in Blue Phantom. In-phantom dose distributions of clinical SRS fields are calculated using the OPT and the clinical Brainlab iPlan pencil-beam. Within the 90% isodose-line(ROI), the average dose difference between the calculations and radiochromic film measurements are assessed. Results: The maximum field, focal spot and secondary source sizes for the OPT are 15×15cm{sup 2}, (0,0), and 32.3mm respectively. The OPT St input at 1.0 and 2.0cm fields are increased by 4.5% and 1.5% from BASE. The calculated output of the BASE and OPT underestimate by 16.1%–3.2% respectively at 0.5×0.5cm{sup 2} field and 3.1%−0.02% respectively at 1.0×1.0cm{sup 2} field. The depth doses at 10cm are within 3.5% and 0.4% of measurements for 0.5×0.5 and 1.0×1.0cm{sup 2}. The ROI dose of OPT and iPlan are within 1.6% and 0.6% of film measurements for 3.0cm clinical fields. For 1.0cm fields, the ROI dose of OPT underestimate 0.0–2.0% and iPlan overestimates 1.7–2.9% relative to measurements. Conclusion: The small field dose calculation of Eclipse AAA algorithm can be significantly improved by carefully adjusting the input parameters. The larger deviation of the OPT for 0.5×0.5cm{sup 2} field from measurements can be attributed to the lowest 1.0cm field size input limit of AAA. The OPT compares reasonably well with the iPlan pencil-beam and measurements.

60 APPLIED LIFE SCIENCES↗

SU-E-T-328: Dosimetric Impact of Cobalt-Chrome Stabilization Hardware in Paraspinal Radiation Therapy

Purpose: Due to saturation, high density materials Result in an apparent density of 3.2 g/cm{sup 3} in CT images. The true density of traditional titanium stabilization rods (∼4.4 g/cm{sup 3}) is typically ignored in treatment planning. This may not be acceptable for new cobalt-chrome rods with a density of 8.5 g/cm{sup 3}. This study reports the dosimetric impact of cobalt-chrome rods in paraspinal radiotherapy. Methods: For titanium and cobalt-chrome rods, two planning studies were done for both IMRT and VMAT in Varian Eclipse using AAA. 1) The effect of planning without assigning the true rod density was assessed by comparing plans generated with the apparent density and recalculated with the true density for titanium and cobalt-chrome. 2) To test if TPS can compensate for high density rods during optimization. Furthermore, TPS calculation accuracy was verified using MapCheck for a single 20 x 10 cm{sup 2} field. The MapCheck was incrementally shifted to achieve measurement resolution of 1 mm. Results: PTV coverage was ∼0.3% and ∼4.7% lower in plans that were recalculated with the true rod density of titanium and cobalt-chrome, respectively. PTV coverage can be maintained if the correct density is used in optimization. Measurements showed that TPS overestimated the dose locally by up to 11% for cobalt-chrome rods and up to 4% for titanium rods if the density is incorrect. With density corrected, maximum local differences of 6% and 3% were seen for cobalt-chrome and titanium rods, respectively. At 2 cm beneath a rod, electrons scattered from the side of the rod increased the lateral dose and diminished as depth increases. TPS was not able to account for this effect properly even with the true rod density assigned. Conclusion: Neglecting the true density of cobalt-chrome rods can cause under coverage to the PTV. Assigning the correct density during treatment planning can minimize unexpected decrease in PTV dose.

60 APPLIED LIFE SCIENCES↗

SU-F-BRD-15: The Impact of Dose Calculation Algorithm and Hounsfield Units Conversion Tables On Plan Dosimetry for Lung SBRT

Purpose: To assess dosimetric differences in IMRT lung stereotactic body radiotherapy (SBRT) plans calculated with Varian AAA and Acuros (AXB) and with vendor-supplied (V) versus in-house (IH) measured Hounsfield units (HU) to mass and HU to electron density conversion tables. Methods: In-house conversion tables were measured using Gammex 472 density-plug phantom. IMRT plans (6 MV, Varian TrueBeam, 6–9 coplanar fields) meeting departmental coverage and normal tissue constraints were retrospectively generated for 10 lung SBRT cases using Eclipse Vn 10.0.28 AAA with in-house tables (AAA/IH). Using these monitor units and MLC sequences, plans were recalculated with AAA and vendor tables (AAA/V) and with AXB with both tables (AXB/IH and AXB/V). Ratios to corresponding AAA/IH values were calculated for PTV D95, D01, D99, mean-dose, total and ipsilateral lung V20 and chestwall V30. Statistical significance of differences was judged by Wilcoxon Signed Rank Test (p<0.05). Results: For HU<−400 the vendor HU-mass density table was notably below the IH table. PTV D95 ratios to AAA/IH, averaged over all patients, are 0.963±0.073 (p=0.508), 0.914±0.126 (p=0.011), and 0.998±0.001 (p=0.005) for AXB/IH, AXB/V and AAA/V respectively. Total lung V20 ratios are 1.006±0.046 (p=0.386), 0.975±0.080 (p=0.514) and 0.998±0.002 (p=0.007); ipsilateral lung V20 ratios are 1.008±0.041(p=0.284), 0.977±0.076 (p=0.443), and 0.998±0.018 (p=0.005) for AXB/IH, AXB/V and AAA/V respectively. In 7 cases, ratios to AAA/IH were within ± 5% for all indices studied. For 3 cases characterized by very low lung density and small PTV (19.99±8.09 c.c.), PTV D95 ratio for AXB/V ranged from 67.4% to 85.9%, AXB/IH D95 ratio ranged from 81.6% to 93.4%; there were large differences in other studied indices. Conclusion: For AXB users, careful attention to HU conversion tables is important, as they can significantly impact AXB (but not AAA) lung SBRT plans. Algorithm selection is also important for small targets in low density lung.

60 APPLIED LIFE SCIENCES↗

SU-E-T-52: Beam Data Comparison for 20 Linear Accelerators in One Network

Purpose: To compare photon beam data for the 20 Varian linear accelerators (TrueBeam, iX, and EX models) in use at five centers in the same network with the intent to model with one set of beam data in Eclipsec. Methods: Varian linear accelerators, TrueBeam (3), 21 EX, iX, and Trilogy (14), and 6 EX (3), installed between 1999 and 2014 have their 6 MV and 15 MV x-ray beams reevaluated. Full commissioning, including output factors (St), percent depth doses (PDD), and off-axis profiles, was recently performed for a TrueBeam with a cc04 ion chamber in an IBA Blue phantom. Similarly, a subset of beam data for each of the other accelerators was measured recently as follows: for 3×3, 10×10, and 30×30 cm{sup 2} field sizes, flatness and penumbra (80–20%) were measured at dmax and 10 cm depths, PDD were measured at 10 and 20 cm depths, and St were measured at 5 cm depth. Measurement results for all machines were compared. Results: For 15 high-energy (6 and 15 MV) and 3 low-energy machines (6MV only): 1) PDD agreed within 1.4% at 10 and 20 cm depths; 2) penumbra agreed within 1.0 mm at dmax and 10 cm depths; 3) flatness was within 1.3% at dmax and 10 cm depths; and 4) with exception of the three low energy machines, output factors were within 1.1% and 0.5% for 3×3 and 30×30 cm{sup 2}, respectively. Measurement uncertainty, not quantified here, accounts for some of these differences. Conclusion: Measured beam data from 15 high-energy Varian linacs are consistent enough that they can be classified using one beam data set in Eclipse. Two additional high-energy machines are removed from this group until their data are further confirmed. Three low-energy machines will be in a separate class based upon differences in output factors (St)

07 ISOTOPE AND RADIATION SOURCES↗

SU-E-T-440: Elliptical Source Model for IMRT and VMAT with Complex Modulation

Purpose: To improve dose calculation accuracy for highly modulated fields in IMRT and VMAT using an elliptical source model. Methods: For 2 TrueBeam linacs equipped with Millennium and HD MLCs, the source model of 6 and 15 MV beams was optimized with adjustments of the focal spot dimensions in the Varian Eclipse TPS. Starting from the measured focal spot size of 1.75 × 1.75 mm, the y-dimension of the source was varied while the x-dimension was kept constant. In addition, all other modeling parameters such as the extrafocal source and dosimetric leaf gap remained unchanged. The different models were compared with measured penumbra for jaws and MLC using ion chamber and diode. For 2 IMRT and 2 VMAT cases, the calculated doses were compared with radiochromic film and EPID measurements. Results: A source size of 1.75 × 0.75 mm was found to be optimal for beam modeling. The calculated penumbra (80–20) of a MLCdefined open field was within 0.8 mm compare to measurement for both the inline and crossline profile for various field sizes and depths. The dose gradients in the direction perpendicular to the MLC travel direction was better modeled compared to the source model with a circular focal spot of 1.75 mm for the fields with rigorous MLC modulation. Local differences up to 8% were found in those regions. Conclusion: The conventional source model using a symmetric focal spot tends to overestimate the penumbra perpendicular to the MLC travel direction, resulting in an inaccurate dose calculation especially for fields with complex MLC modulation. This can be improved with an elliptical source model and it can be considered as a standard as IMRT and VMAT treatments are becoming a norm for the clinic.

60 APPLIED LIFE SCIENCES↗

SU-E-T-496: A Study of Two Commercial Dose Calculation Algorithms in Low Density Phantom

Purpose: Some lung cancer patients have very low lung density due to comorbidities. We investigate calculation accuracy of Eclipse AAA and Acuros(AXB) using a phantom that simulates this situation. Methods: A 2.5 x 5.0 x 5 cm (long) solid water inhomogeneity positioned 10 cm deep in a Balsa lung phantom (density 0.099 gm/cc) was irradiated with an off-center field such that the central axis was parallel to one side of the inhomogeneity. Radiochromic films were placed at 2.5cm(S1) and 5cm(S2) depths. After CT scanning, Hounsfield Units(HU) were converted to electron(ρe) and mass(ρm) density using in-house(IH) and vendor-supplied(V) calibration curves. IH electron densities were generated using a commercial electron density phantom. The phantom was exposed to 6 MV 3x3 and 20x20 fields. Dose distributions were calculated using the AAA and AXB algorithms. Results: The HU of BW is -910±40 which translates to ρe of 0.088±0.050(IH) and 0.090±0.050(V), and ρm of 0.101±0.045(IH) and 0.103±0.039(V). Both ρe(V) and ρm(V) are higher than ρe(IH) and ρm(IH) respectively by 1.4-5.3% and 0.5-12.3%. The average calculated dose inside the solid water ‘tumor’ are within 3.7% and 2.4% of measurements for both calibrations and field sizes using AAA and AXB. Within 10mm outside the ‘tumor’, AAA on average underestimates by 18.3% and 17.0% respectively for 3x3 using IH and V. AXB underestimates by 5.9%(S1)-6.6%(S2) and 13.1%(S1)-16.0%(S2) respectively using IH and V. For 20x20, AAA and AXB underestimate by 2.8%(S1)-4.4%(S2) and 0.3%(S1)-1.4%(S2) respectively with either calibration. Conclusion: The difference in the HU calibration between V and IH is not of clinical significance in normal field sizes. In the low density region of small fields, the calculations from both algorithms differ significantly from measurements. This may be attributed to the insufficient lateral electron transport modeled by two algorithms resulting in the over-estimation in penumbra expansion.

60 APPLIED LIFE SCIENCES↗

Structural and Functional Analyses of a Conserved Hydrophobic Pocket of Flavivirus Methyltransferase

The flavivirus methyltransferase (MTase) sequentially methylates the N7 and 2'-O positions of the viral RNA cap (GpppA-RNA {yields} m(7)GpppA-RNA {yields} m(7)GpppAm-RNA), using S-adenosyl-l-methionine (AdoMet) as a methyl donor. We report here that sinefungin (SIN), an AdoMet analog, inhibits several flaviviruses through suppression of viral MTase. The crystal structure of West Nile virus MTase in complex with SIN inhibitor at 2.0-{angstrom} resolution revealed a flavivirus-conserved hydrophobic pocket located next to the AdoMet-binding site. The pocket is functionally critical in the viral replication and cap methylations. In addition, the N7 methylation efficiency was found to correlate with the viral replication ability. Thus, SIN analogs with modifications that interact with the hydrophobic pocket are potential specific inhibitors of flavivirus MTase.

59 BASIC BIOLOGICAL SCIENCES↗

Effects of H2O and H2O2 on Thermal Desorption of Tritium from Stainless Steel

Tritiated stainless steel was subjected to thermal desorption at various temperatures, different temperature profiles, and in the presence of different helium carrier gas additives. In all cases the identities of the desorbing tritiated species were characterized as either water-soluble or insoluble. The samples were found to contain 1.1 mCi±0.4 mCi. Approximately ninety-five percent of this activity was released in molecular water-soluble form. Additives of H2O or H2O2 to dry helium carrier gas increase the desorption rate and lower the maximum temperature to which the sample must be heated, in order to remove the bulk of the tritium. The measurements validate a method of decontamination of tritiated steel and suggest a technique that can be used to further explore the mechanisms of desorption from tritiated metals.

Quinlan, M J↗